HOUSTON — The American Society of Plastic Surgeons (ASPS), the preeminent global authority in the field of plastic and reconstructive surgery, has officially inaugurated Lynn A. Damitz, MD, FACS, as its new President. The transition occurred during Plastic Surgery The Meeting, the Society’s annual flagship scientific conference held in Houston, marking the beginning of a one-year tenure that will extend through September 19, 2027.
Dr. Damitz, a distinguished surgeon and academic leader, steps into this role at a pivotal moment for the medical specialty. As the world’s largest organization of board-certified plastic surgeons, the ASPS wields significant influence over global surgical standards, patient safety protocols, and legislative advocacy. Dr. Damitz’s leadership is expected to emphasize the intersection of clinical innovation and rigorous, data-driven patient advocacy.
The Appointment: A Legacy of Leadership
The announcement of Dr. Damitz’s presidency is the culmination of over two decades of dedicated service to the Society. Since joining the ASPS in 2002, Dr. Damitz has consistently occupied roles of increasing responsibility, signaling a career-long commitment to the institutional health of the profession.
Before ascending to the presidency, Dr. Damitz served as the ASPS Board Vice President of Health Policy and Advocacy. In that capacity, she was a central figure in some of the most significant legislative victories for the plastic surgery community in recent years. Her tenure was marked by a relentless pursuit of modernized healthcare laws, specifically her work regarding the Women’s Health and Cancer Rights Act (WHCRA). By pushing for the expansion of insurance coverage for breast reconstruction and ensuring that patients with congenital conditions have equitable access to life-altering procedures, Dr. Damitz has established herself as a fierce defender of patient rights.
Professional Chronology: From Chapel Hill to the National Stage
To understand the vision Dr. Damitz brings to the ASPS, one must examine the foundation of her medical career.
- Educational Foundation: Dr. Damitz earned her medical degree from the Hahnemann University School of Medicine. Her surgical training took place at the University of North Carolina (UNC) at Chapel Hill, where she completed residencies in both general surgery and plastic surgery.
- Advanced Specialization: Following her residency, she undertook advanced fellowships focusing on plastic, breast, and aesthetic surgery, providing her with the technical breadth required for complex reconstructive work.
- Academic and Clinical Leadership: Currently, Dr. Damitz serves as the Chief of the Division of Plastic and Reconstructive Surgery, Director of Aesthetic Surgery, and Professor of Surgery at the University of North Carolina School of Medicine. This dual role—balancing the rigorous demands of an academic surgeon with the administrative duties of a division chief—has prepared her for the high-level governance required of the ASPS President.
- ASPS Milestone: A key indicator of her influence within the Society was her three-year tenure as Chair of the ASPS Membership Committee. This role gave her a unique, grassroots understanding of the challenges faced by board-certified plastic surgeons at various stages of their careers, from residents to seasoned practitioners.
The Vision: Quality Metrics and Patient Safety
In her inaugural address to the Society, Dr. Damitz outlined a clear and ambitious agenda. Central to her platform is the implementation of "quality metrics and outcomes-based data."
"I am deeply honored to lead the American Society of Plastic Surgeons and represent our dedicated members worldwide," Dr. Damitz stated. "As plastic surgeons, our responsibility extends beyond the operating room. Patient safety must guide every decision we make, from education to innovation. I look forward to supporting the work of board-certified plastic surgeons and reinforcing our specialty’s leadership in delivering exceptional patient outcomes."
H3: Prioritizing Evidence-Based Surgery
Dr. Damitz’s emphasis on outcomes-based data is not merely administrative; it is a strategic move to insulate the specialty against external scrutiny. In an era where aesthetic surgery is increasingly commodified, the ASPS aims to distinguish board-certified surgeons through their commitment to validated clinical results. By leveraging data, Dr. Damitz intends to create a feedback loop where surgical techniques are continuously refined based on objective, multi-institutional outcomes rather than anecdotal success.
H3: Advocacy and Policy
The incoming president plans to continue her advocacy for policies that improve patient access to care. This includes:
- Legislative Reform: Continuing the work to strengthen the WHCRA and closing loopholes that prevent patients from receiving necessary reconstructive care.
- Multidisciplinary Initiatives: Strengthening ties between plastic surgery and other oncology-focused specialties to ensure that breast reconstruction is viewed as a standard of care, not an elective luxury.
- Global Collaboration: Given the global footprint of the ASPS, Dr. Damitz intends to foster international partnerships that allow for the exchange of best practices in trauma reconstruction and aesthetic innovation.
Supporting Data: The Impact of ASPS Advocacy
The influence of the ASPS under leaders like Dr. Damitz is backed by a robust organizational structure that oversees thousands of board-certified surgeons. The Society currently functions as the primary educational resource for the specialty, providing:
- Clinical Research: Funding and oversight for longitudinal studies on breast, facial, and body reconstruction.
- Safety Standards: The development of the "Patient Safety Checklist," which has become a benchmark for surgical centers globally.
- Public Education: A sustained campaign to educate the public on the critical difference between board-certified plastic surgeons and those who lack specialized training.
Data collected by the ASPS indicates that reconstructive surgery—particularly for breast cancer patients—drastically improves mental health outcomes, reduces long-term medical costs associated with trauma, and improves patient satisfaction. Dr. Damitz’s goal is to turn these data points into legislative leverage, ensuring that insurance providers recognize the long-term cost-benefit of covering reconstructive procedures.
Official Responses and Industry Outlook
The medical community has reacted positively to the announcement, with many highlighting Dr. Damitz’s reputation as a "surgeon’s surgeon." Colleagues note that her background in both complex oncologic reconstruction and aesthetic surgery gives her a unique perspective on the holistic needs of the patient.
"Dr. Damitz possesses the rare combination of technical surgical mastery and the political acumen required to navigate the complexities of modern healthcare," said one senior member of the ASPS Board. "Her focus on accountability and education is exactly what the Society needs to maintain its leadership position in the coming years."
The academic community at UNC has also lauded the appointment, noting that her leadership brings prestige to the university’s surgery department and highlights the importance of academic surgeons in shaping national policy.
Implications: The Road Ahead
Dr. Damitz’s one-year term will likely be defined by how effectively she can bridge the gap between rapid technological advancement and the slow, often cumbersome nature of healthcare policy.
The Challenge of Modernization
The emergence of new technologies—such as AI-driven surgical planning and regenerative medicine—presents both opportunities and risks. Dr. Damitz will need to lead the Society in creating ethical guidelines for these technologies, ensuring that patient safety remains the "North Star" of innovation.
The Fight for Access
As healthcare systems globally grapple with rising costs and staffing shortages, the access to specialized surgery remains under threat. By advocating for improved coverage, Dr. Damitz is effectively fighting for the viability of the specialty itself. If patients cannot access care, the specialty loses its ability to practice and improve.
A Legacy of Excellence
By the time her term concludes on September 19, 2027, Dr. Damitz hopes to leave behind a more transparent and more accessible specialty. Her focus on "collaboration, innovation, and international partnership" signals a shift toward a more interconnected global surgical community.
In her own words, the responsibility of the plastic surgeon is not confined to the operating theater. It extends to the halls of government, the pages of academic journals, and the patient-doctor relationship. Under Dr. Damitz’s guidance, the American Society of Plastic Surgeons is poised to continue its mission of excellence, ensuring that the highest standards of surgical care remain the standard for all.
For patients and practitioners alike, the next year represents a period of potential progress, marked by a leader who understands that the future of plastic surgery is built on the twin pillars of rigorous scientific inquiry and unwavering compassion for the patient. As she assumes the presidency, Dr. Damitz is not just leading an organization; she is stewarding the future of a specialty that touches millions of lives annually.
About the Author
